首页> 美国卫生研究院文献>other >Antibodies against G-protein coupled receptors: novel uses in screening and drug development
【2h】

Antibodies against G-protein coupled receptors: novel uses in screening and drug development

机译:抗G蛋白偶联受体的抗体:在筛选和药物开发中的新用途

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antibodies are components of the body’s humoral immune system that are generated in response to foreign pathogens. Modern biomedical research has employed these very specific and efficient molecules designed by nature in the diagnosis of diseases, localization of gene products as well as in the rapid screening of targets for drug discovery and testing. In addition, the introduction of antibodies with fluorescent or enzymatic tags has significantly contributed to advances in imaging and microarray technology, which are revolutionizing disease research and the search for effective therapeutics. More recently antibodies have been used in the isolation of dimeric G protein-coupled receptor (GPCR) complexes. In this review we discuss antibodies as powerful research tools for studying GPCRs, and their potential to be developed as drugs themselves.
机译:抗体是人体对体液免疫系统的组成部分,是针对外来病原体产生的。现代生物医学研究已将这些由自然界设计的非常特异性和高效的分子用于疾病的诊断,基因产物的定位以及用于药物发现和测试的目标的快速筛选。此外,带有荧光或酶标记的抗体的引入显着促进了成像和微阵列技术的发展,这正在革新疾病研究和寻找有效的治疗方法。最近,抗体已用于二聚体G蛋白偶联受体(GPCR)复合物的分离。在这篇综述中,我们讨论了抗体作为研究GPCR的强大研究工具,以及它们作为药物本身的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号